SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,997 | +4148.9% | 97 | +9600.0% | 0.00% | – |
| Q2 2023 | $47 | +11.9% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $42 | +10.5% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $38 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1 | -99.5% | 0.00% | – |
| Q2 2021 | $12,000 | 0.0% | 205 | +32.3% | 0.00% | – |
| Q1 2021 | $12,000 | +33.3% | 155 | +24.0% | 0.00% | – |
| Q4 2019 | $9,000 | +350.0% | 125 | +733.3% | 0.00% | – |
| Q2 2018 | $2,000 | – | 15 | +66.7% | 0.00% | – |
| Q3 2016 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 9 | -30.8% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 13 | -94.0% | 0.00% | – |
| Q4 2015 | $13,000 | – | 218 | +3014.3% | 0.00% | – |
| Q3 2015 | $0 | – | 7 | -46.2% | 0.00% | – |
| Q2 2015 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |